pirmagrel has been researched along with 6-ketoprostaglandin f1 alpha in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (78.57) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, TA; Danchak, M; Douglas, FL; Fomsgaard, JS; Kim, YD; Myers, AK; Peppard, J; Schaffer, AV; Viswanathan, T | 1 |
| Glovsky, MM; Horvath, SJ; Morganroth, ML; Schoeneich, SO; Till, GO; Ward, PA | 1 |
| Edhag, O; Gréen, K; Henriksson, P; Rasmanis, G; Vesterqvist, O | 1 |
| Kadowitz, PJ; Mayeux, PR; McNamara, DB | 1 |
| FitzGerald, GA; Nowak, J | 1 |
| Doran, JB; FitzGerald, GA; Reilly, IA; Smith, B | 1 |
| Butler, KD; Shand, RA; Wallis, RB | 1 |
| Ahmed, SW; Douglas, F; Foegh, ML; Franco, K; Katz, NM; Kim, YD; Ku, E; Ng, L; Siegelman, R; Wallace, RB | 1 |
| Anner, H; Hechtman, HB; Kaufman, RP; Kobzik, L; Shepro, D; Valeri, CR | 1 |
| DeCampli, WM; Goodwin, D; Handen, CE; Kosek, JC; Miller, DC; Mitchell, RS | 1 |
| Brigmon, L; Lawson, DL; Mehta, J; Mehta, P; Ostrowski, N | 1 |
| Brash, A; Fitzgerald, G; Oates, JA | 1 |
| Cash, WD; Chertock, H; Ku, EC; McPherson, SE; Signor, C | 1 |
| Maguire, ED; Wallis, RB | 1 |
1 trial(s) available for pirmagrel and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Arteriosclerosis; beta-Thromboglobulin; Epoprostenol; Female; Humans; Imidazoles; Male; Middle Aged; Platelet Aggregation; Platelet Factor 4; Pyridines; Thromboxane B2; Thromboxane-A Synthase | 1986 |
13 other study(ies) available for pirmagrel and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Comparison of thromboxane synthetase inhibitor and methylprednisolone effects on protamine responses in dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dogs; Drug Interactions; Hemodynamics; Imidazoles; Methylprednisolone; Protamines; Pyridines; Thromboxane B2; Thromboxane-A Synthase | 1992 |
C3a57-77, a C-terminal peptide, causes thromboxane-dependent pulmonary vascular constriction in isolated perfused rat lungs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzofurans; Blood Pressure; Complement C3a; Cyclooxygenase Inhibitors; Imidazoles; In Vitro Techniques; Indomethacin; Lung; Male; Peptide Fragments; Perfusion; Pyridines; Rats; Thromboxane B2; Thromboxane-A Synthase; Vasoconstriction | 1990 |
Thromboxane synthase inhibition: "endoperoxide shunt phenomenon" does not occur in healthy humans in vivo.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Epoprostenol; Humans; Imidazoles; Male; Pyridines; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1990 |
Evidence for a bidirectional prostaglandin endoperoxide shunt between platelets and the bovine coronary artery.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Cattle; Coronary Vessels; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme System; Epoprostenol; Humans; Imidazoles; Intramolecular Oxidoreductases; Isomerases; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Pyridines; Thromboxane B2; Thromboxane-A Synthase | 1989 |
Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man.
Topics: 6-Ketoprostaglandin F1 alpha; Bleeding Time; Blood Platelets; Blood Vessels; Epoprostenol; Gas Chromatography-Mass Spectrometry; Humans; Imidazoles; Prostaglandin Endoperoxides; Pyridines; Reference Values; Thromboxane A2; Thromboxane B2 | 1989 |
The effects of modulation of prostanoid metabolism on the thoracic platelet accumulation induced by intravenous administration of collagen in the guinea-pig.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Platelets; Chromium Radioisotopes; Collagen; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Guinea Pigs; Imidazoles; Injections, Intravenous; Platelet Aggregation; Platelet Count; Prostaglandins; Pyridines; Thorax; Thromboxane B2; Thromboxanes | 1986 |
Effects of CGS-13080, a thromboxane inhibitor, on pulmonary vascular resistance in patients after mitral valve replacement surgery.
Topics: 6-Ketoprostaglandin F1 alpha; Cardiopulmonary Bypass; Heart Valve Prosthesis; Hemodynamics; Humans; Hypertension, Pulmonary; Imidazoles; Mitral Valve; Postoperative Complications; Pulmonary Circulation; Pyridines; Thromboxane B2; Thromboxane-A Synthase; Vascular Resistance | 1988 |
A high plasma prostaglandin to thromboxane ratio protects against renal ischemia.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzofurans; Creatinine; Evaluation Studies as Topic; Ibuprofen; Imidazoles; Ischemia; Kidney; Kidney Tubular Necrosis, Acute; Male; Methacrylates; Pyridines; Rats; Thromboxane B2; Thromboxane-A Synthase | 1987 |
Pharmacological, hematological, and physiological effects of a new thromboxane synthetase inhibitor (CGS-13080) during cardiopulmonary bypass in dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood; Cardiopulmonary Bypass; Dogs; Double-Blind Method; Drug Evaluation, Preclinical; Female; Hemodynamics; Imidazoles; Male; Platelet Count; Pyridines; Random Allocation; Thromboxane B2; Thromboxane-A Synthase; Time Factors | 1986 |
Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Platelets; Calcimycin; Calcium Chloride; Collagen; Epoprostenol; Imidazoles; Indomethacin; Leukocytes; Oxidoreductases; Platelet Aggregation; Pyridines; Rabbits; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1985 |
Comparison of the effects of selective inhibition of thromboxane synthase with those of inhibition of the cyclooxygenase enzyme in man.
Topics: 6-Ketoprostaglandin F1 alpha; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Imidazoles; Male; Oxidoreductases; Pyridines; Thromboxane-A Synthase; Time Factors | 1984 |
Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Platelets; Humans; Imidazoles; In Vitro Techniques; Male; Oxidoreductases; Prostaglandins E; Pyridines; Rats; Rats, Inbred Strains; Thromboxane B2; Thromboxane-A Synthase | 1983 |
In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Platelets; Collagen; Imidazoles; Indoles; Indomethacin; Male; Oxidoreductases; Pyridines; Radioimmunoassay; Rats; Rats, Inbred Strains; Thrombocytopenia; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1983 |